BLCO EBITDA | Bausch & Lomb Corp

Bausch & Lomb Corp (BLCO) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $83.00M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $33.00M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $95.00M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$11.00M; Depreciation and amortization (m).

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$83.00M	(m)	$1.39B	(m)	$71.00M*	$153.00M*	(m)	(m)	$588.00M	-$1.00M
2026-03-31	Reported	(m)	$33.00M	(m)	$1.24B	(m)	$100.00M	$32.00M	(m)	(m)	$544.00M	$6.00M
2025-09-30	Reported	(m)	$95.00M	(m)	$1.28B	(m)	$74.00M*	$137.00M*	(m)	(m)	$528.00M	$22.00M
2025-06-30	Reported	(m)	-$11.00M	(m)	$1.28B	(m)	$89.00M*	$35.00M*	(m)	(m)	$579.00M	-$89.00M
2025-03-31	Reported	(m)	-$83.00M	(m)	$1.14B	(m)	$110.00M	-$25.00M	(m)	(m)	$563.00M	$31.00M
2024-09-30	Reported	(m)	$43.00M	(m)	$1.20B	(m)	$60.00M*	$154.00M*	(m)	(m)	$511.00M	-$66.00M
2024-06-30	Reported	(m)	$26.00M	(m)	$1.22B	(m)	$72.00M*	$15.00M*	(m)	(m)	$535.00M	$72.00M
2024-03-31	Reported	(m)	$6.00M	(m)	$1.10B	(m)	$67.00M	$41.00M	(m)	(m)	$504.00M	$73.00M
2023-09-30	Reported	(m)	$40.00M	(m)	$1.01B	(m)	$33.00M*	$48.00M*	(m)	(m)	$418.00M	$45.00M
2023-06-30	Reported	(m)	$43.00M	(m)	$1.03B	(m)	$27.00M*	-$24.00M*	(m)	(m)	$417.00M	$10.00M
2023-03-31	Reported	(m)	-$2.00M	(m)	$931.00M	(m)	$37.00M	-$56.00M	(m)	(m)	$418.00M	$33.00M
2022-09-30	Reported	(m)	$46.00M	(m)	$942.00M	(m)	$49.00M*	$27.00M*	(m)	(m)	$381.00M	$34.00M
2022-06-30	Reported	(m)	$56.00M	(m)	$941.00M	(m)	$34.00M*	$156.00M*	(m)	(m)	$368.00M	$20.00M
2022-03-31	Reported	(m)	$54.00M	(m)	$889.00M	(m)	$42.00M	$3.00M	(m)	(m)	$343.00M	$6.00M
2021-09-30	Reported	(m)	$94.00M	(m)	$949.00M	(m)	$41.00M*	$273.00M*	(m)	(m)	$348.00M	$25.00M
2021-06-30	Reported	(m)	$58.00M	(m)	$934.00M	(m)	$45.00M*	$250.00M*	(m)	(m)	$358.00M	$21.00M
2021-03-31	Reported	(m)	$85.00M	(m)	$881.00M	(m)	$45.00M	$188.00M	(m)	(m)	$318.00M	$47.00M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$113.00M	(m)	$5.10B	(m)	$349.00M	$283.00M	(m)	(m)	$2.23B	$35.00M
2024-12-31	Reported	(m)	$162.00M	(m)	$4.79B	(m)	$291.00M	$232.00M	(m)	(m)	$2.08B	$71.00M
2023-12-31	Reported	(m)	$130.00M	(m)	$4.15B	(m)	$181.00M	-$17.00M	(m)	(m)	$1.74B	$82.00M
2022-12-31	Reported	(m)	$207.00M	(m)	$3.77B	(m)	$175.00M	$345.00M	(m)	(m)	$1.48B	$58.00M
2021-12-31	Reported	(m)	$329.00M	(m)	$3.77B	(m)	$193.00M	$873.00M	(m)	(m)	$1.39B	$125.00M
2020-12-31	Reported	(m)	$260.00M	(m)	$3.41B	(m)	$253.00M	$522.00M	(m)	(m)	$1.25B	$307.00M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Warby Parker Inc. (WRBY)	United States	$2.970B
COOPER COMPANIES, INC. (COO)	United States	$10.533B	24.09
National Vision Holdings, Inc. (EYE)	United States	$1.297B
STAAR SURGICAL CO (STAA)	United States	$0.957B	362.70
RxSight, Inc. (RXST)	United States	$0.197B
Innovative Eyewear Inc (LUCY)	United States	$0.008B